Improved Clinical Outcomes During Long-term Osilodrostat Treatment of Cushing Disease With Normalization of Late-night Salivary Cortisol and Urinary Free Cortisol

By sjmartinez • November 29, 2024

Newell-Price J, Fleseriu M, Pivonello R, Feelders RA, Gadelha MR, Lacroix A, Witek P, Heaney AP, Piacentini A, Pedroncelli AM, Biller BMK. Improved Clinical Outcomes During Long-term Osilodrostat Treatment of Cushing Disease With Normalization of Late-night Salivary Cortisol and Urinary Free Cortisol. J Endocr Soc. 2024 Nov 12;9(1):bvae201. doi: 10.1210/jendso/bvae201. PMID: 39610378; PMCID: PMC11604051.

Tags: cortisol normalization, Cushing disease, Endocrinology, hypercortisolism, long-term treatment, osilodrostat, Publications

Workshop Report-Heterogeneity and Successful Aging Part II: Approaches to Investigate Heterogeneity in Aging Research

Kumar V, Hevener AL, Ruby JG, Sebastiani P, Kuchel GA; Participants of the NIA Heterogeneity and Successful Aging Workshop. Workshop Report-Heterogeneity and Successful Aging Part[...]

Genetic Testing Referral Rates for Pheochromocytoma and Paraganglioma in an Academic Tertiary Centre

Ruhle B, Kim NE, Ngo S, Hughes EG, Sajed DP, Yu R, Wu JX, Yeh MW, Livhits MJ. Genetic Testing Referral Rates for Pheochromocytoma and[...]

Efficacy, Tolerability, and Safety of Glucagon-Like Peptide 1 Receptor Agonists (GLP1-RA) in Kidney Transplant Recipients With Diabetes

Zelada H, Campana M, Kawai K, Redden D, Agarwal G, Gutierrez OM, Kumar V. Efficacy, Tolerability, and Safety of Glucagon-Like Peptide 1 Receptor Agonists (GLP1-RA)[...]